Betty, I learned my lesson in 1990 with the tech crash then. I wish I had held onto my 3com and Oracle for long term gains. I took the short-term route and missed out on years of growth. Have not made that mistake with JMAR.
What do you think sales and earnings will be in 1998? The ARPA $10 million will all be in 1998 for JTC I believe, so with around a 20% margin, that gives JMAR about 2 million, or .10 per share on that alone. Add to this no drain from CATS. Aside from this, these are additional sources of revenue...
* Test & Measurement Division &
Mirage, Galaxy, and Horizon ->hard drive industry
* Motion Control & Positioning
* Bright Light/ Microlight ->Micromachining and new products
* Lightning - Semiconductor Repair Systems
* Hermetic Laser Sealing of medical devices -> pacemakers, etc..
* UltraPrecision Manufacturing
* Light Knife ->BD, and potentially new alliances for new uses such as cutting materials, dental, introduction of drugs to the body.
* XRL -> Possible sales to Universities, and chip manufacturers for Research in 1998
I have also heard that JMAR's Mirage is the best in the industry and is being sought out by Hard Drive makers. If this is indeed true, JMAR should be taking a much larger role in this area in 1998.
My guess is that JMAR should have sales at least double this year's and perhaps much higher. Add to this that earnings will not be hampered by drains from CATS. The ARPA contract builds in a big earnings boost, not to mention a much more enhanced Bright Light technology.
Only 1 1/2 weeks left of tax loss selling. Looks like the worst is over for most tech stocks. An odd combination of seasonal drop, Korean and Asian crisis, tax loss selling.
--Bilberry |
